Anaplastic Malignant Neoplasm — Trials

Anaplastic Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 290
Ph III recruiting: 18
Growth YoY: +34.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (324)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04105374	Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma	withdrawn	Phase 2 / Phase 3	0	NRG OncologyOTHER	0	May 7, 2026	clinicaltrials
NCT04021082	CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)	withdrawn	Phase 2 / Phase 3	0	Portola PharmaceuticalsINDUSTRY	0	Feb 21, 2023